Bioleaching review part B:

This review describes the historical development and current state of metals leaching and sulfide mineral biooxidation by the minerals industries. During the past 20 years commercial processes employing microorganisms for mineral recovery have progressed from rather uncontrolled copper dump leaching to mineral oxidation and leaching in designed bioheaps for oxidation of refractory gold ores and for copper recovery. Also during this period of time, stirred tank bioleaching has been commercialized for cobalt recovery and for biooxidation of refractory gold ores. Chalcopyrite bioleaching in stirred tanks is on the verge of commercialization. Commercial applications of biohydrometallurgy have advanced due to favorable process economics and, in some cases, reduced environmental problems compared to conventional metal recovery processes such as smelting. Process development has included recognition of the importance of aeration of bioheaps, and improvements in stirred tank reactor design and operation. Concurrently, knowledge of the key microorganisms involved in these processes has advanced, aided by advances in molecular biology to characterize microbial populations.     

Medical Innovation in a Children's Hospital: ‘Diseases desperate grown by desperate appliance are relieved,or not at all’

A balance needs to be struck between facilitating compassionate access to innovative treatments for those in desperate need, and the duty to protect such vulnerable individuals from the harms of untested/unlicensed treatments. We introduced a principle‐based framework (2009) to evaluate such requests and describe its application in the context of recently evolved UK, US and European regulatory processes. 24 referrals (20 individual; four group) were received by our quaternary children's hospital Clinical Ethics Committee (CEC) over the 5‐year period (2011‐16). The CEC‐rapid response group evaluated individual cases within 48‐hours; the main referrers being haematology/oncology, immunology or transplant services (14). Most requests were for drug/vaccine/pre‐trial access (13) or biological/cellular therapies (8). The majority of individual requests were approved (19/20); neutral or negative opinions were given in 5, including 3 group requests. Recently evolved regulatory processes share common criteria and conditions to our framework including: demonstration of clinical need; sound scientific basis with lack of viable alternative; risks‐benefit/best interests evaluation; arrangements for fully informed consent; no compromise of arrangements to test treatment for licensing purposes; consideration of resource implications. There are differences between individual processes and with our framework, with respect to procedures, scope, application format, costs and obligation to make available all outcome data. Our experience has emphasized the need for an independent, principled, consistent, fair and transparent response to the increasing demand for innovative treatment on a compassionate basis. We believe that there is a need for harmonization of the recent proliferation of regulation and legislation in this area.     

Inhibition of Na+-dependent Ca2+ efflux from heart mitochondria by amiloride analogues

The Na+-induced release of accumulated Ca2+ from heart mitochondria is inhibited by amiloride, benzamil and several other amiloride analogues. These drugs do not affect uptake or release of Ca2+ mediated by the ruthenium red-sensitive uniporter and their effects, like those of diltiazem and other Ca2+-antagonists, appear to be localized principally at the Na+/Ca2+ antiporter of the mitochondrion. Benzamil inhibits Na+/Ca2+ antiport non-competitively with respect to [Na+] with a Ki of 167 microM. In the presence of 1.5 mM Pi the Ki for benzamil inhibition of this reaction is decreased to 87 microM.     

Phosphorylation of casein by human erythrocyte membrane-bound protein kinase: competition of casein with endogenous substrates

Summary The possibility that spectrin and band-3 protein are phosphorylated by the same membrane-bound protein kinase was investigated by adding casein to unsealed erythrocyte ghosts and examining competition of the three proteins for phosphorylation. The extent of spectrin and band-3 protein phosphorylation was reduced by up to approximately 55%. This indicated that casein was competing with these endogenous substrates for phosphorylation and was most probably phosphorylated by the same protein kinase(s). Furthermore, the extent of inhibition of the phosphorylation of the two endogenous substrates was indistinguishable over the range of casein concentrations tested (0.1 to 5mg/ml). This indicates that spectrin and band-3 protein may be phosphorylated by the same protein kinase. In contrast, casein was found to have no effect on the cAMP-dependent phosphorylation of band 4.5. This result indicates that casein only competes with the endogenous proteins phosphorylated by the cAMP-independent protein kinase(s).The extent of reduction of endogenous substrate phosphorylation in the presence of casein was found to be constant over incubation periods of 1 to 15 min, indicating that this reduction was not due to consumption of ATP.Since the spectrin and band-3 protein phosphorylations were specifically and identically reduced by casein and these reductions were not due to the ATP consumption or to a general alteration of the membrane, we conclude that the two substrates are likely phosphorylated by one kinase which also phosphorylates casein.     

The uptake and extrusion of monovalent cations by isolated heart mitochondria

Summary The factors involved in the movement of monovalent cations across the inner membrane of the isolated heart mitochondrion are reviewed. The evidence suggests that the energy-dependent uptake of K⁺ and Na⁺ which results in swelling of the matrix is an electrophoretic response to a negative internal potential. There are no clear cut indications that this electrophoretic cation movement is carrier-mediated and possible modes of entry which do not require a carrier are examined. The evidence also suggests that the monovalent cation for proton exchanger (Na⁺ > K⁺) present in the membrane may participate in the energy-dependent extrusion of accumulated ions. The two processes, electrophoretic cation uptake (swelling) and exchange-dependent cation extrusion (contraction) may represent a means of controlling the volume of the mitochondrion within the functioning cell. A number of indications point to the possibility that the volume control process may be mediated by the divalent cations Ca⁺² and Mg⁺². Studies with mercurial reagents also implicate certain membrane thiol groups in the postulated volume control process.An invited article.     

Matrix free Mg2+ and the regulation of mitochondrial volume

Mitochondria must maintain volume homeostasis inorder to carry out oxidative phosphorylation. It has been postulatedthat the concentration of freeMg²⁺([Mg²⁺]) serves as thesensor of matrix volume and regulates aK⁺-extrudingK⁺/H⁺antiport (K. D. Garlid. J. Biol. Chem.255: 11273-11279, 1980). To test this hypothesis, the fluorescentprobe furaptra was used to monitor[Mg²⁺] and freeCa²⁺ concentration ([Ca²⁺]) in the matrix ofisolated beef heart mitochondria, andK⁺/H⁺antiport activity was measured by passive swelling in potassium acetate. Concentrations that result in 50% inhibition of maximum activity of 92 µM matrix [Mg²⁺] and 2.2 µM[Ca²⁺] were determined for theK⁺/H⁺ antiport. Untreated mitochondria average670 µM matrix [Mg²⁺], a value that would permit <1%of maximumK⁺/H⁺antiport activity. Hypotonic swelling results in large decreases inmatrix [Mg²⁺], butswelling due to accumulation of acetate salts does not alter[Mg²⁺]. Swelling inphosphate salts decreases matrix[Mg²⁺], but not tolevels that permit appreciable antiport activity. We conclude that1) it is unlikely that matrix[Mg²⁺] serves as themitochondrial volume sensor, 2) ifK⁺/H⁺antiport functions as a volume control transporter, it is probably regulated by factors other than[Mg²⁺], and3) alternative mechanisms formitochondrial volume control should be considered.

     

Ion transport by heart mitochondria. Retention and loss of energy coupling in aged heart mitochondria

The retention and loss of energy-coupling reactions in isolated beef heart mitochondria have been examined under anaerobic conditions using suspending media chosen to mimic the intracellular milieu. In long-term incubations at 37 °C, a loose coupling develops which can be controlled by adding serum albumin. This lesion closely resembles that produced by addition of free fatty acids which has been described in previous studies. Shorter incubation times produce an increased susceptibility to hydrogen peroxide which is characterized by elevated ATPase activity, increased permeability to monovalent cations, and increased proton ejection on transition from the anaerobic to the aerobic state. This peroxide sensitivity is prevented by chelators such as EGTA and appears to involve a time-dependent release of metal ions. Of the metabolites which are known to increase in concentration in the ischemic heart cell, Na⁺, P₁, lactate, and H⁺ all promote swelling of isolated heart mitochondria and contribute to a decline in energy coupling. The relationship of these results to the pathological deterioration of mitochondria in ischemic heart tissue is discussed.